According to the report, FDA claimed that in the eight-year time period, it did not receive sufficient boosts in its annual appropriation for salaries and expenses to cover annual pay increases.
GAO criticizes FDA
The General Accounting Office released results of an eight-year study which indicated that between Fiscal Year 1994 and Fiscal Year 2001, FDA cut back on required inspections of medical product manufacturing facilities and reviews of over-the-counter pharmaceuticals and generic products in order to provide employees with annual pay increases.
Dec 31st, 2002
